FDA Inspection
Cipla, Ltd.Cipla, Ltd. – FDA Inspection, Dec 9, 2016
Record Details
This FDA Inspection record concerns Cipla, Ltd., with an inspection on December 9, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0150dc7b-0ea7-4467-9129-865c909e274d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 997481
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cipla, Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2018 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 1, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cipla, Ltd.
- FDA Inspection 1236690 - 2024-05-08
- FDA Inspection 1084973 - 2019-03-20
- FDA Inspection 1073182 - 2018-11-30
- FDA Inspection 882706 - 2014-05-23
- FDA Inspection 755727 - 2011-12-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.